Publications in collaboration with researchers from Hospital Clínico San Carlos de Madrid (44)

2024

  1. Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries

    British Journal of Surgery, Vol. 111, Núm. 1

  2. Goodbye Hartmann trial: a prospective, international, multicenter, observational study on the current use of a surgical procedure developed a century ago

    World Journal of Emergency Surgery, Vol. 19, Núm. 1

2023

  1. Risk factors for anastomotic leakage and postoperative outcomes after total and subtotal colectomy: A nationwide retrospective cohort study (RIALTCOT Study Collaborative Group)

    Colorectal Disease, Vol. 25, Núm. 3, pp. 420-430

  2. Stoma-free survival after anastomotic leak following rectal cancer resection: worldwide cohort of 2470 patients

    British Journal of Surgery, Vol. 110, Núm. 12, pp. 1863-1876

2022

  1. Evaluation of AIF-1 (Allograft Inflammatory Factor-1) as a Biomarker of Crohn’s Disease Severity

    Biomedicines, Vol. 10, Núm. 3

2021

  1. Impact of Bacillus Calmette-Gue´rin (BCG) vaccination on postoperative mortality in patients with perioperative SARS-CoV-2 infection

    BJS Open

  2. Institutional factors associated with adherence to enhanced recovery protocols for colorectal surgery: Secondary analysis of a multicenter study

    Journal of Clinical Anesthesia, Vol. 74

  3. Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score

    British Journal of Surgery, Vol. 19, Núm. 4

  4. Outcomes from elective colorectal cancer surgery during the SARS-CoV-2 pandemic

    Colorectal Disease, Vol. 23, Núm. 3, pp. 732-749

2020

  1. Neuromuscular blockade management and postoperative outcomes in enhanced recovery colorectal surgery: Secondary analysis of POWER trial

    Minerva Anestesiologica, Vol. 87, Núm. 1, pp. 13-25

  2. Schwann cell hamartoma as an incidental finding in a colonoscopy

    Gastroenterologia y Hepatologia, Vol. 43, Núm. 9, pp. 516-517

  3. Usefulness of monitoring antitumor necrosis factor serum levels during the induction phase in patients with Crohn's disease

    European Journal of Gastroenterology and Hepatology, Vol. 32, Núm. 5, pp. 588-596

2019

  1. Functional rare variants influence the clinical response to anti-TNF therapy in Crohn’s disease

    Therapeutic Advances in Gastroenterology, Vol. 12

2018

  1. Aeem-sego position statement on menopausal hormone therapy

    Progresos de Obstetricia y Ginecologia, Vol. 61, Núm. 3, pp. 230-234

2016

  1. Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximab

    Biochemical Pharmacology, Vol. 122, pp. 33-41

2007

  1. MDR1 polymorphisms and response to azathioprine therapy in patients with Crohn's disease

    Inflammatory Bowel Diseases, Vol. 13, Núm. 5, pp. 585-590

2004

  1. Reviewing the mechanism of action of thiopurine drugs: Towards a new paradigm in clinical practice

    Medical Science Monitor, Vol. 10, Núm. 11

2003

  1. Clinical value of p53, c-erbB-2, CEA and CA125 regarding relapse, metastasis and death in resectable non-small cell lung cancer

    International Journal of Cancer, Vol. 107, Núm. 5, pp. 781-790

1999

  1. Bullous and hemorrhagic lesions

    Archives of Dermatology, Vol. 135, Núm. 1, pp. 81

1998

  1. Superficial granulomatous pyoderma

    Dermatology, Vol. 196, Núm. 3, pp. 358-360